Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | TP53 | P04637 | 4/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.34 |
| ▸ | NPC1 | O15118 | 3/20 | 0.34 |
| ▸ | RAB9A | P51151 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | XDH | P47989 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8431662 | 0.81 | ALDH1A1 (0.55) | ALDH1A1TSHRHDAC8CHRNB2CHRNB4 | |
| SCHEMBL5066949 | 0.81 | ALDH1A1 (0.55) | ALDH1A1TSHRHDAC8CHRNB2CHRNB4 | |
| SCHEMBL5209430 | 0.80 | MAPT (0.44) | ALDH1A1MAPTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL5072084 | 0.78 | ALDH1A1 (0.46) | ALDH1A1TSHRHDAC8CHRNB2CHRNB4 | |
| SCHEMBL13074628 | 0.78 | ALDH1A1 (0.46) | ALDH1A1TSHRHDAC8CHRNB2CHRNB4 | |
| SCHEMBL24691363 | 0.77 | ALDH1A1 (0.50) | ALDH1A1TSHRHDAC8CHRNB2CHRNB4 | |
| SCHEMBL6389194 | 0.77 | ALDH1A1 (0.50) | ALDH1A1TSHRHDAC8CHRNB2CHRNB4 | |
| SCHEMBL7714658 | 0.77 | ALDH1A1 (0.52) | ALDH1A1MAPTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL10746889 | 0.77 | ALDH1A1 (0.44) | ALDH1A1TSHRHDAC8CHRNB2CHRNB4 | |
| SCHEMBL9580112 | 0.77 | ALDH1A1 (0.44) | ALDH1A1TSHRHDAC8CHRNB2CHRNB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024042159-A1 | CONDUCTIVE PRESSURE SENSITIVE ADHESIVE | HENKEL AG & CO. KGAA (DE) | 2024-02-29 | — | — | WO | disclosed |
| EP-3501482-A1 | TWO-PACKAGE DENTAL ADHESIVE COMPOSITION | Tokuyama Dental Corporation (JP) | 2019-06-26 | — | — | EP | disclosed |
| US-20110230420-A1 | RELEASABLE CONJUGATES FOR NUCLEIC ACIDS DELIVERY SYSTEMS | ENZON PHARMACEUTICALS, INC. (US) | 2011-09-22 | — | — | US | disclosed |
| US-20080038669-A1 | NON-TRULY-SPHERICAL HIGH-MOLECULAR FINE PARTICLES, PROCESS FOR PRODUCING THE SAME, INKJET INK COMPOSITION CONTAINING FINE PARTICLES, LITHOGRAPHIC PRINTING PLATE USING THE SAME, PROCESS FOR PRODUCING PRINTING PLATE, AND ELECTROPHORETIC PARTICLES-CONTAINING COMPOSITION CONTAINING FINE PARTICLES | FUJIFILM CORPORATION (JP) | 2008-02-14 | — | — | US | disclosed |
| EP-0762197-B1 | Photographic recording material | AGFA GEVAERT AG (DE) | 2000-01-12 | — | — | EP | disclosed |
| US-5888719-A | CONTINING A POLYMER; DARK DECAY STABILITY | AGFA-GEVAERT AG (DE) | 1999-03-30 | — | — | US | disclosed |
| US-5674668-A | Photographic recording material | AGFA-GEVAERT (DE) | 1997-10-07 | — | — | US | disclosed |
| EP-0762197-A1 | Photographic recording material | Agfa-Gevaert AG (DE) | 1997-03-12 | — | — | EP | disclosed |
| US-5518877-A | POLYPEPTIDE-ADDITION POLYMER | AGFA-GEVAERT AG (DE) | 1996-05-21 | — | — | US | disclosed |
| EP-0666498-A2 | Silver halide photographic material | Agfa-Gevaert AG (DE) | 1995-08-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230420-A1 | RELEASABLE CONJUGATES FOR NUCLEIC ACIDS DELIVERY SYSTEMS | PHAX, KPNA6, KPNA2 | ALDH1A1 3693/4885TSHR 2363/4885HDAC8 715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.